What is Viatris's treasury stock?

Viatris (VTRS) reported treasury stock of $1.01B in Q1 2026.

How has Viatris's treasury stock changed year-over-year?

Viatris's treasury stock increased by 48.1% year-over-year, from $679.8M to $1.01B.

What does treasury stock mean?

Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

Viatris VTRS Treasury Stock

Treasury Stock at other companies

PfizerPFE

$115.19B+0.2%

McKessonMCK

$32.01B+16.6%

ANI PharmaceuticalsANIP

$53M+70.7%

CencoraCOR

$10.44B+1.0%

AMP

Amphastar PharmaceuticalsAMPH

$438M+27.3%

Scilex Holding CompanySCLX

$76.92M0.0%

Other financials

Income statement

See full

Revenue$3.5B+8.1%

Gross profit$1.2B-0.3%

Operating income-$79.7M+97.2%

Net income$176.4M+106%

EPS (diluted)$0.15+106%

Balance sheet

See full

Cash & equivalents$1.8B+139%

Total debt$14.6B+1.0%

Total equity$14.7B-6.3%

Total assets$36.8B-4.3%

Cash flow

See full

Operating cash flow$388.3M-27.5%

CapEx$39.9M-6.3%

Free cash flow$348.4M-29.3%

Valuation

See full

Market cap$20.08B+84.7%

Enterprise value$32.88B+31.2%

P/S1.4×+0.6×

Profitability

See full

Gross margin34.4%-2.5pp

Operating margin1%—

Net margin-2%-1.0pp

FCF margin12.3%-1.0pp

Returns & leverage

See full

Return on equity-2%-0.9pp

Debt / equity1×+0.1×

Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viatris's treasury stock?: Viatris (VTRS) reported treasury stock of $1.01B in Q1 2026.
How has Viatris's treasury stock changed year-over-year?: Viatris's treasury stock increased by 48.1% year-over-year, from $679.8M to $1.01B.
What does treasury stock mean?: Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.